Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...

Welcome to E-Menai

--(BUSINESS ambien with alcohol WIRE)--Jun 22, 2009 - Kowa Pharmaceuticals America, Inc. is a privately held multinational company headquartered in Nagoya, Japan. It is focused in the R&D of innovative and patented drug delivery systems as well as innovative pharmaceutical products primarily for oral and topical administration.ch. is a specialty pharmaceutical company engaged in research, development and manufacture of Aversion(R) (abuse deterrent) Technology product candidates and other innovative abuse deterrent technologies. When used in this press release, the words "estimate," "project," "anticipate," "expect," "intend," "believe," and similar expressions are intended to identify forward-looking statements.

.


NewsA Level

--(BUSINESS WIRE)--Jun 22, 2009 - Kowa Pharmaceuticals America, Inc. In randomized clinical trials, Cambia was shown to be effective not only in migraine pain, but also in treating photophobia (sensitivity to light), phonophobia (sensitivity to sound), and nausea commonly associated with migraine attacks. About Acurox Tablets Acurox is a patented, orally administered, immediate release tablet containing oxycodone HCl as its sole active analgesic ingredient with a proposed indication for the relief of moderate-to-severe pain. King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. Examples of forward looking statements in this press release include statements concerning the Companies' expectations regarding the timing or content of their response to the FDA concerning the Complete Response Letter and the Companies' expectations regarding any meeting with the FDA to discuss the Complete Response Letter..